论文信息 - Benzodipyrazoles: a new class of potent CDK2 inhibitors.

Benzodipyrazoles: a new class of potent CDK2 inhibitors.

The synthesis and the preliminary expansion of this new class of CDK2 inhibitors are presented. The synthesis was accomplished using a solution-phase protocol amenable to rapid parallel expansion and suitable to be scaled-up in view of possible lead development. Following a medicinal chemistry program aimed at improving cell permeability and selectivity, a series of compounds with nanomolar activity in the biochemical assay and able to efficiently inhibit tumor cell proliferation has been obtained.

[1] Nader Fotouhi,et al. Cell cycle inhibitors for the treatment of cancer , 2003 .

[2] S. Knapp,et al. Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors. , 2003, Journal of molecular biology.

[3] G. Stein. The molecular basis of cell cycle and growth control , 1999 .

[4] A. Huwe,et al. Small molecules as inhibitors of cyclin-dependent kinases. , 2003, Angewandte Chemie.

[5] E. Sausville. Cyclin-dependent kinase modulators studied at the NCI: pre-clinical and clinical studies. , 2003, Current medicinal chemistry. Anti-cancer agents.

[6] P. Fischer,et al. CDK inhibitors in clinical development for the treatment of cancer , 2003, Expert opinion on investigational drugs.